Primus In News
How to ensure sustainability and wider stakeholder acceptability in NLEM revisions
07-12-2022
Nilaya Varma, CEO and Managing Director, Primus Partners shares his thoughts on the 4th revision of the National List of Essential Medicines, in particular releasing frequent revisions to the list as well as providing greater financial incentives to pharma companies.
Explore Related Insights
- Technical support and IT advisory for State Health System Strengthening Project
- Monthly Policy Update – March 2021
- Beyond Boundaries: India’s Digital Public Infrastructure (DPI) Model for Global Progress
- Overcoming Capacity and Compliance Challenges to Strengthen the State’s Agribusiness Network for Sustainable Farming
